pharma&
Purvi Patel, PharmD, is an experienced professional in the pharmaceutical industry with a solid background in medical affairs and pharmacovigilance. Currently serving as a Senior Medical Affairs Manager at pharma& since June 2023, Purvi previously held the same title at Clovis Oncology from June 2017 to May 2023, during which time also served as Senior Pharmacovigilance Operations Manager and Pharmacovigilance Operations Manager. Prior experience includes a role as Clinical Safety Associate at Otsuka Pharmaceutical Companies (U.S.) from March 2016 to June 2017 and as a Cardiovascular and Hematology Safety Data Specialist as well as Medical Record Extraction Coordinator at Bayer from December 2013 to March 2016. Purvi Patel earned a Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences.
This person is not in any teams
This person is not in any offices
pharma&
1 followers
pharmaand GmbH (pharma&), a privately owned global company, aspires to breathe new life into proven medicines through our agile and fully integrated business model, guaranteeing the enduring availability, dependability, and quality of essential drugs worldwide that patients and healthcare providers rely on. Whether a former blockbuster or niche medicine, we acquire the worldwide rights to specialty treatments to secure long-term access to established and essential medicines across various specialized therapy areas, doing whatever it takes to maintain and develop the value of these medicines for all who depend on them. We’ve acquired and integrated 11 medicines over the past five years, expanding our portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. Our unique, fully integrated model across pharma&’s subsidiaries, joint ventures, and partners enables us to provide our portfolio of medicines to eligible healthcare providers and patients worldwide, spanning the continuum of manufacturing, distribution, administration/access, and patient support.